Preventive Effects of Escherichia coli Strain Nissle 1917 on Acute and Chronic Intestinal Inflammation in Two Different Murine Models of Colitis

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 2, 2004, Pages 372-378

  Schultz, Michael ^a   Strauch, Ulrike G ^a   Linde, Hans Jörg ^a   Watzl, Sonja ^a   Obermeier, Florian ^a   Göttl, Claudia ^a   Dunger, Nadja ^a   Grunwald, Nicole ^a   Schölmerich, Jürgen ^a   Rath, Heiko C ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXTRAN; DRINKING WATER; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 5; INTERLEUKIN 6; SODIUM SULFATE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; BACTERIUM COLONY; BACTERIUM CULTURE; CHRONIC INFLAMMATION; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HISTOPATHOLOGY; LYMPHOCYTE TRANSFER; MESENTERY LYMPH NODE; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCID MOUSE; SCORING SYSTEM; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; ANIMALS; BACTERIAL TRANSLOCATION; CD4-POSITIVE T-LYMPHOCYTES; CECUM; CHRONIC DISEASE; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; L-SELECTIN; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, SCID; PROBIOTICS;

EID: 12144287724     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.2.372-378.2004     Document Type: Article

References (45)

1. high T cells to SCID recipients. J. Immunol. 158:3464-3473.
2. Axelsson, L. G., E. Landström, A. C. Bylund-Fellenius, and T. Midtvedt. 1997. Dextran sulfate sodium induced colitis and sulfasalazine treatment in bacteria free mice. Gastroenterology 108:A775.
3. Axelsson, L. G., T. Midtvedt, and A. C. Bylund-Fellenius. 1996. The role of intestinal bacteria, bacterial translocation and endotoxin in dextran sodium sulphate-induced colitis in the mouse. Microb. Ecol. Health Dis. 9:225-237.
4. Baumgart, D. C., and A. Dignass. 2002. Intestinal barrier function. Curr. Opin. Clin. Nutr. Metab. Care 5:685-694.
5. Berg, R. D. 1983. Bacterial translocation from the gastrointestinal tracts of mice receiving immunosuppressive chemotherapeutic agents. Curr. Microbiol. 8:285-292.
6. Bienenstock, J., R. E. Riley, G. S. Neigh, S. Waserman, and P. Keith. 2002. Probiotics in the management and prevention of atopy. Clin. Rev. Allergy Immunol. 22:275-285.
7. Borruel, N., M. Carol, F. Casellas, M. Antolin, F. de Lara, E. Espín, J. Naval, F. Guarner, and J. R. Malagelada. 2003. Increased mucosal tumor necrosis factor a production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 51:659-664.
8. Boudeau, J., A. L. Glasser, S. Julien, J. F. Colombel, and A. Darfeuille-Michaud. 2003. Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease. Aliment. Pharmacol. Ther. 18:45-56.
9. Cong, Y., C. T. Weaver, A. Lazenby, and C. O. Elson. 2002. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. 169:6112-6119.
10. Cooper, H. S., S. N. S. Murthy, R. S. Shah, and D. J. Sedergran. 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Investig. 69:238-249.
11. Cremonini, F., S. Di Caro, E. C. Nista, F. Bartolozzi, G. Capelli, G. Gasbarrini, and A. Gasbarrini. 2002. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhea. Aliment. Pharmacol. Ther. 16:1461-1467.
12. Dieleman, L. A., M. S. Goerres, A. Arends, D. Sprengers, C. Torrice, F. Hoentjen, W. Grenther, and R. B. Sartor. 2003. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52:370-376.
13. Dieleman, L. A., B. U. Ridwan, G. S. Tennyson, K. W. Beagley, R. P. Bucy, and C. O. Elson. 1994. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107:1643-1652.
14. Elson, C. O. 2000. Commensal bacteria as targets in Crohn's disease. Gastroenterology 119:254-257.
15. Isolauri, E. 2003. Probiotics for infectious diarrhea. Gut 52:436-437.
16. Ito, H. 2003. Anti-interleukin-6 therapy for Crohn's disease. Curr. Pharm. Des. 9:295-305.
17. Kruis, W., P. Fric, M. Stolte, and the Mutaflor Study Group. 2001. Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine. Gastroenterology 120:A680.
18. Kruis, W., E. Schutz, P. Fric, B. Fixa, G. Judmaier, and M. Stolte. 1997. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther. 11:853-858.
19. Kucharzik, T., N. Lugering, K. Rautenberg, A. Lugering, M. A. Schmidt, R. Stoll, and W. Domschke. 2000. Role of M cells in intestinal barrier function. Ann. N. Y. Acad. Sci. 915:171-183.
20. Lammers, K. M., U. Helwig, E. Swennen, F. Rizzello, A. Venturi, E. Caramelli, M. A. Kamm, P. Brigidi, P. Gionchetti, and M. Campieri. 2002. Effect of probiotic strains on interleukin-8 production by HT-29/19A cells. Am. J. Gastroenterol. 97:1182-1186.
21. Lilly, D. M., and R. H. Stilwell. 1965. Probiotics: growth promoting factors produced by microorganisms. Science 47:747-748.
22. Mack, D. R., S. Michail, S. Wei, L. McDougall, and M. A. Hollingsworth. 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276:G941-G950.
23. Madsen, K. L., A. Cornish, P. Soper, C. McKaigney, H. Jijon, C. Yachimec, J. Doyle, L. Jewell, and C. De Simone. 2001. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121:580-591.
24. Madsen, K. L., J. S. Doyle, L. D. Jewell, M. M. Tavernini, and R. N. Fedorak. 1999. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116:1107-1114.
25. Malin, M., H. Suomalainen, M. Saxelin, and E. Isolauri. 1996. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann. Nutr. Metab. 40:137-145.
26. + T cells: insights into the regulatory role of interleukin-6 on apoptosis. Pathobiology 70:170-176.
27. Neurath, M. F., B. Weigmann, S. Finotto, J. Glickmann, E. Nieuwenhuis, H. lijima, A. Mizoguchi, E. Mizoguchi, J. Mudter, P. R. Galle, A. Bhan, F. Autschbach, B. M. Sullivan, S. J. Szabo, L. H. Glimcher, and R. S. Blumberg. 2002. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195:1129-1143.
28. Ölschläger, T., A. Altenhöfer, and J. Hacker. 2001. Inhibition of Salmonella typhimurium invasion into intestinal cells by the probiotic strain E. coli Nissle 1917. Gastroenterology 120:A1682.
29. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5:1461-1471.
30. low subset. J. Exp. Med. 172:1701-1708.
31. Rath, H. C., M. Schultz, R. Freitag, L. A. Dieleman, F. Li, H.-J. Linde, J. Schoelmerich, and R. B. Sartor. 2001. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect. Immun. 69:2277-2285.
32. Rath, H. C., H. H. Herfarth, J. S. Ikeda, W. B. Grenther, T. E. Hamm, Jr., E. Balish, J. D. Taurog, R. E. Hammer, K. H. Wilson, and R. B. Sartor. 1996. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human β2 microglobulin transgenic rats. J. Clin. Investig. 98:945-953.
33. Rembacken, B. J., A. M. Snelling, P. M. Hawkey, D. M. Chalmers, and A. T. Axon. 1999. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354:635-639.
34. Sartor, R. B. 2002. Microbial agents in the pathogenesis, differential diagnosis, and complications of inflammatory bowel disease, p. 435-458. In M. J. Blaser, P. D. Smith, and J. I. Ravdin (ed.), Infections of the gastrointestinal tract. Raven Press, Ltd., New York, N.Y.
35. Schultz, M., H.-J. Linde, N. Lehn, K. Zimmermann, J. Grossmann, W. Falk, and J. Schoelmerich. 2002. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG (L. GG) in healthy volunteers. J. Dairy Res. 70:165-173.
36. Schultz, M., J. Schoelmerich, and H. C. Rath. 2003. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel disease. Dig. Dis. 21:105-128.
37. Schultz, M., C. Veltkamp, L. A. Dieleman, R. B. Wyrick, S. L. Tonkongy, and R. B. Sartor. 2002. Lactobacillus plantarum 299v in treatment and prevention of spontaneous colitis in IL-10-deficient mice. Inflamm. Bowel Dis. 8:71-80.
38. Schultz, M., S. L. Tonkonogy, R. K. Sellon, C. Veltkamp, V. L. Godfrey, J. Kwon, W. B. Grenther, E. Balish, I. Horak, and R. B. Sartor. 1999. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am. J. Physiol. 276:G1461-G1472.
39. Sellon, R. K., S. L. Tonkonogy, M. Schultz, L. A. Dieleman, W. B. Grenther, E. Balish, D. Rennick, and R. B. Sartor. 1998. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66:5224-5231.
40. Tannock, G. W., K. Munro, H. J. Harmsen, G. W. Welling, J. Smart, and P. K. Gopal. 2000. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl. Environ. Microbiol. 66:2578-2588.
41. Ulisse, S., P. Gionchetti, S. D'Alò, F. P. Russo, I. Pesce, G. Ricci, F. Rizzello, U. Helwig, M. G. Cifone, M. Campieri, and C. De Simone. 2001. Expression of cytokines, inducible nitric oxide synthetase and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am. J. Gastroenterol. 96:2691-2699.
42. Venturi, A., P. Gionchetti, F. Rizzello, R. Johansson, E. Zucconi, P. Brigidi, D. Matteuzzi, and M. Campieri. 1999. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment. Pharmacol. Ther. 13: 1103-1108.
43. Versalovic, J., T. Koeuth, and J. R. Lupski. 1991. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 19:6823-6831.
44. Wells, C. L., M. A. Maddaus, and R. L. Simmons. 1987. Role of the macrophage in the translocation of intestinal bacteria. Arch. Surg. 122:48-53.
45. Wiest, R., and H. C. Rath. 2003. Bacterial translocation in the gut. Best Pract. Res. Clin. Gastroenterol. 17:397-425.